Caffeine consumption and risk of dyskinesia in CALM-PD.

Caffeine consumption and risk of dyskinesia in CALM-PD.
复制标题

DOI:
10.1002/mds.25319
复制
发表时间:
2013-03
期刊:
影响因子:
8.6
通讯作者:
Schwarzschild, Michael A.
Schwarzschild, Michael A.
中科院分区:
医学1区
文献类型:
--
作者:
Wills, Anne-Marie A.;Eberly, Shirley;Tennis, Marsha;Lang, Anthony E.;Messing, Susan;Togasaki, Daniel;Tanner, Caroline M.;Kamp, Cornelia;Chen, Jiang-Fan;Oakes, David;McDermott, Michael P.;Schwarzschild, Michael A.

文献摘要

参考文献

被引文献

相似文献

腺苷A2 A受体拮抗剂减少或预防左旋多巴诱导的运动障碍动物模型中运动障碍的发展。我们在激动剂普拉克索与左旋多巴治疗帕金森病运动并发症的比较(CALM-PD)和CALM队列扩展研究中,使用校正年龄、基线帕金森病严重程度、部位和普拉克索或左旋多巴初始治疗的考克斯比例风险模型,检查了自我报告的A2 A受体拮抗剂咖啡因摄入量与至运动障碍时间之间的相关性。与每天饮用< 4盎司咖啡的受试者相比,每天饮用> 12盎司咖啡的受试者发生运动障碍的校正风险比为0.61(95%置信区间,0.37-1.01)。对于每天摄入4至12盎司的受试者,调整后的风险比为0.73(C.I. 0.46-1.15)(趋势检验,p = 0.05)。这些结果支持了咖啡因可能减少运动障碍的可能性。
Adenosine A2A receptor antagonists reduce or prevent the development of dyskinesia in animal models of levodopa-induced dyskinesia. We examined the association between self-reported intake of the A2A receptor antagonist caffeine and time to dyskinesia in the Comparison of the Agonist Pramipexole with Levodopa on Motor Complications of Parkinson’s Disease (CALM-PD) and CALM Cohort extension studies, using a Cox proportional hazards model adjusting for age, baseline Parkinson’s severity, site, and initial treatment with pramipexole or levodopa. For subjects who consumed > 12 ounces of coffee/day, the adjusted hazard ratio for the development of dyskinesia was 0.61 (95% confidence interval, 0.37–1.01) compared to subjects who consumed < 4 ounces/day. For subjects who consumed between 4 and 12 ounces/day, the adjusted hazard ratio was 0.73 (C.I. 0.46–1.15) (test for trend, p = 0.05). These results support the possibility that caffeine may reduce the likelihood of developing dyskinesia.
DOI: 10.1523/jneurosci.22-03-01054.2002
发表时间: 2002-02-01
影响因子: 5.3
作者:
Fredduzzi, S;Moratalla, R;Chen, JF
通讯作者: Chen, JF
帕金森病运动障碍和非运动障碍患者体内腺苷 2A 受体的可用性
DOI: 10.1212/wnl.0b013e31821ccce4
发表时间: 2011-05-01
期刊: NEUROLOGY
影响因子: 9.9
作者:
Ramlackhansingh, A. F.;Bose, S. K.;Brooks, D. J.
通讯作者: Brooks, D. J.
DOI: 10.1016/s1474-4422(11)70012-6
发表时间: 2011-03-01
期刊: LANCET NEUROLOGY
影响因子: 48
作者:
Hauser, Robert A.;Cantillon, Marc;Wolski, Kenneth
通讯作者: Wolski, Kenneth
DOI: 10.1212/wnl.0b013e318263570d
发表时间: 2012-08-01
期刊: NEUROLOGY
影响因子: 9.9
作者:
Postuma, Ronald B.;Lang, Anthony E.;Shah, Binit
通讯作者: Shah, Binit
DOI: 10.1016/j.brainres.2010.08.099
发表时间: 2011-01-07
期刊: Brain research
影响因子: 2.9
作者:
Xiao D;Cassin JJ;Healy B;Burdett TC;Chen JF;Fredholm BB;Schwarzschild MA
通讯作者: Schwarzschild MA